Online Appointment Dr. Sanjeev Chaudhary Cardiologist with Email Id Fortis Hospital Gurgaon India

Dr. Sanjeev Chaudhary

MBBS, MD – Medicine, DNB – Cardiology
Director – Cardiology
Cardiologist – 15 Years of Experience

Doctor Profile

Introduction

He is a renowned interventional cardiologist with an experience of over 12 years. His last assignment was as senior interventional cardiologist at Paras hospitals Gurgaon where he worked for more than 5 years. He has a vast experience in performing coronary angioplasty and has performed over five thousand interventional procedures. He has a keen interest in clinical research and is principal investigator in many clinical research studies. He has contributed maximum number of cases all over India in multinational TAO study. He has a special interest in primary angioplasty ( angioplasty in acute heart attack) and coronary artery disease in diabetics.

Special interest

  • coronary angioplasty
  • coronary angiography
  • Coronary disease in the diabetics.
  • Complex coronary interventions.

Fellowships and Memberships

  • Fellow of DNB, Cardiology Batra Hospital & Research Center, New Delhi 2002 – 2005
  • Consultant, Cardiology, Fortis Hospital Noida 2005 – 2006
  • Consultant, Cardiology, Escorts Heart Institute & Research Center, Delhi, 2006-2008
  • Senior Consultant, Cardiology, Paras Hospitals, Gurgaon, 2008-2013
  • Director, Cardiology, Fortis Memorial Research Institute,Gurgaon, 2013 – Present

Awards and Achievements

Awarded double gold medalist in PGIMS, Rohtak

Unique Contribution

  • Lifetime Member of Association of Physicians of India and
  • Member of Indian Society of Echocardiography
  • Life Membership Cardiology Society of India.
  • Fellow of European Society of Cardiology.
  • TAO STUDY Principal Investigator : Randomized double blind triple-dummy trial to compare the efficacy of otamixaban with Unfractionated Heparin & eptifibatide, in patients with Unstable angina Non ST segment Elevation Myocardial Infarction scheduled to undergo an early.
  • ELIXA STUDY Principal Investigator : A randomized, double blind, placebo group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetic patients after an Acute Coronary Syndrome
  • EPICOR ASIA Principal Investigator : Long term follow up of antithrombotic management patterns in acute coronary syndrome patients in Asia.
<< return to doctors

Scroll to Top